[HTML][HTML] Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease
AR Roda, G Serra-Mir, L Montoliu-Gaya… - Neural regeneration …, 2022 - journals.lww.com
Alzheimer's disease is a neurodegenerative disease that accounts for most of the 50-million
dementia cases worldwide in 2018. A large amount of evidence supports the amyloid …
dementia cases worldwide in 2018. A large amount of evidence supports the amyloid …
[HTML][HTML] Neuroinflammation in Alzheimer's disease
IG Onyango, GV Jauregui, M Čarná, JP Bennett Jr… - Biomedicines, 2021 - mdpi.com
Alzheimer's disease (AD) is a neurodegenerative disease associated with human aging.
Ten percent of individuals over 65 years have AD and its prevalence continues to rise with …
Ten percent of individuals over 65 years have AD and its prevalence continues to rise with …
[HTML][HTML] Sexual dimorphism in the 3xTg-AD mouse model and its impact on pre-clinical research
JL Dennison, NR Ricciardi, I Lohse… - Journal of …, 2021 - content.iospress.com
Female sex is a leading risk factor for developing Alzheimer's disease (AD). Sexual
dimorphism in AD is gaining attention as clinical data show that women are not only more …
dimorphism in AD is gaining attention as clinical data show that women are not only more …
[HTML][HTML] Aducanumab and its effects on tau pathology: is this the turning point of amyloid hypothesis?
S Silvestro, A Valeri, E Mazzon - International Journal of Molecular …, 2022 - mdpi.com
Alzheimer's disease (AD) is a neurodegenerative disorder affecting millions of people
around the world. The two main pathological mechanisms underlying the disease are beta …
around the world. The two main pathological mechanisms underlying the disease are beta …
Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's
Alzheimer's disease (AD) is the fifth leading cause of death on the planet. It hallmarks the
presence of amyloid plaques and neurofibrillary tangles in geriatric patients. The condition …
presence of amyloid plaques and neurofibrillary tangles in geriatric patients. The condition …
[HTML][HTML] Cognitive impairment in the 3xTg-AD mouse model of Alzheimer's disease is affected by Aβ-immunotherapy and cognitive stimulation
AR Roda, G Esquerda-Canals, J Martí-Clúa, S Villegas - Pharmaceutics, 2020 - mdpi.com
Clinical symptoms of Alzheimer's Disease (AD) include behavioral alterations and cognitive
impairment. These functional phenotypes early occur in triple-transgenic (3xTg-AD) mice …
impairment. These functional phenotypes early occur in triple-transgenic (3xTg-AD) mice …
Geroprotective interventions in the 3xTg mouse model of Alzheimer's disease
MM Sonsalla, DW Lamming - Geroscience, 2023 - Springer
Alzheimer's disease (AD) is an age-associated neurodegenerative disease. As the
population ages, the increasing prevalence of AD threatens massive healthcare costs in the …
population ages, the increasing prevalence of AD threatens massive healthcare costs in the …
[HTML][HTML] Application of antibody fragments against Aβ with emphasis on combined application with nanoparticles in Alzheimer's disease
ZT Sun, C Ma, GJ Li, XY Zheng, YT Hao… - Frontiers in …, 2021 - frontiersin.org
Alzheimer's disease (AD) is one of the most common neurodegenerative diseases and
accumulating evidences suggest a key role of amyloid-β (Aβ) peptide in the pathogenesis of …
accumulating evidences suggest a key role of amyloid-β (Aβ) peptide in the pathogenesis of …
[HTML][HTML] Fermented Gastrodia elata Bl. Alleviates Cognitive Deficits by Regulating Neurotransmitters and Gut Microbiota in D-Gal/AlCl3-Induced Alzheimer's Disease …
Y Wang, M Zhao, C Xie, L Li, L Lin, Q Li, L Li, F Chen… - Foods, 2024 - mdpi.com
Alzheimer's disease (AD) is a common neurological disease with recognition ability loss
symptoms and a major contributor to dementia cases worldwide. Gastrodia elata Bl.(GE), a …
symptoms and a major contributor to dementia cases worldwide. Gastrodia elata Bl.(GE), a …
Genetic architecture of hippocampus subfields volumes in Alzheimer's disease
J Cai, W Xiong, X Wang, H Tan… - CNS Neuroscience …, 2024 - Wiley Online Library
Background The hippocampus is a heterogeneous structure, comprising histologically and
functionally distinguishable hippocampal subfields. The volume reductions in hippocampal …
functionally distinguishable hippocampal subfields. The volume reductions in hippocampal …